Ranolazine 70771-1499-04

Package NDC

70771-1499-04

Manufacturer: Zydus Lifesciences Limited
Dosage Form: Tablet, Extended Release
Route: Oral
Product Type: Human Prescription Drug
Marketing Start: September 10, 2019
Listing Expires: December 31, 2027
Application: ANDA210188

Need to source Ranolazine? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Ranolazine	500 mg/1

Drug Class

Anti-anginal [EPC]Anti-anginal [EPC]Cytochrome P450 2D6 Inhibitors [MoA]

Selected Package

70771-1499-04Selected

10 BLISTER PACK in 1 CARTON (70771-1499-4) / 10 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (70771-1499-2)

Other packages for this product(3)

70771-1499-01

100 TABLET, EXTENDED RELEASE in 1 BOTTLE (70771-1499-1)

View →

70771-1499-05

500 TABLET, EXTENDED RELEASE in 1 BOTTLE (70771-1499-5)

View →

70771-1499-06

60 TABLET, EXTENDED RELEASE in 1 BOTTLE (70771-1499-6)

View →